112 related articles for article (PubMed ID: 20090448)
21. Imaging findings of granulocyte colony-stimulating factor-producing tumors: a case series and review of the literature.
Kohno S; Furuta A; Arizono S; Tokunaga K; Nakao S; Tanabe M; Kataoka TR; Isoda H; Togashi K
Jpn J Radiol; 2021 Sep; 39(9):857-867. PubMed ID: 34021462
[TBL] [Abstract][Full Text] [Related]
22. F-18 FDG positron emission tomography and benign fractures.
Shon IH; Fogelman I
Clin Nucl Med; 2003 Mar; 28(3):171-5. PubMed ID: 12592121
[TBL] [Abstract][Full Text] [Related]
23. FDG uptake by the bone marrow in NSCLC patients is related to TGF-beta but not to VEGF or G-CSF serum levels.
Van de Wiele C; VandeVyver F; Debruyne C; Philippé J; van Meerbeeck JP
Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):519-22. PubMed ID: 18034241
[TBL] [Abstract][Full Text] [Related]
24. Combined effects of granulocyte colony stimulating factor and radiation.
Drubach LA; Dubois S; Frazier L; Connolly LP
Clin Nucl Med; 2007 Jan; 32(1):39-41. PubMed ID: 17179802
[No Abstract] [Full Text] [Related]
25. 18F-fluorodeoxyglucose-positron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract.
Kim MR; Roh JL; Kim JS; Choi SH; Nam SY; Kim SY
Oral Oncol; 2008 Feb; 44(2):148-52. PubMed ID: 17350879
[TBL] [Abstract][Full Text] [Related]
26. Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies.
Teo BK; Badiee S; Hadi M; Lam T; Johnson L; Seo Y; Bacharach SL; Hasegawa BH; Franc BL
Nucl Med Commun; 2008 Apr; 29(4):359-66. PubMed ID: 18317301
[TBL] [Abstract][Full Text] [Related]
27. Association Between Time Since Administration of Pegylated G-CSF (Pegfilgrastim) and Bone Marrow Uptake on FDG PET/CT: Determination of a Minimum Interval.
Minamimoto R; Baratto L; Iagaru A
AJR Am J Roentgenol; 2022 Feb; 218(2):351-358. PubMed ID: 34467784
[No Abstract] [Full Text] [Related]
28. Active Bone Marrow With Focal FDG Accumulation Mimicking Bone Metastasis With a Case of Early Esophageal Cancer.
Okuyama C; Sasaki N; Nishimura M; Matsushima S; Yoshimatsu R
Clin Nucl Med; 2018 Apr; 43(4):258-261. PubMed ID: 29504964
[TBL] [Abstract][Full Text] [Related]
29. Positron emission tomography and bone metastases.
Fogelman I; Cook G; Israel O; Van der Wall H
Semin Nucl Med; 2005 Apr; 35(2):135-42. PubMed ID: 15765376
[TBL] [Abstract][Full Text] [Related]
30. Diffuse bone marrow accumulation of FDG in a patient with chronic myeloid leukemia mimics hematopoietic cytokine-mediated FDG uptake on positron emission tomography.
Takalkar A; Yu JQ; Kumar R; Xiu Y; Alavi A; Zhuang H
Clin Nucl Med; 2004 Oct; 29(10):637-9. PubMed ID: 15365439
[No Abstract] [Full Text] [Related]
31. Progressive osteoblastic bone metastases in breast cancer negative on FDG-PET.
Huyge V; Garcia C; Vanderstappen A; Alexiou J; Gil T; Flamen P
Clin Nucl Med; 2009 Jul; 34(7):417-20. PubMed ID: 19542943
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of bone marrow FDG uptake in patients with gynecological cancer.
Shimura K; Mabuchi S; Komura N; Yokoi E; Kozasa K; Sasano T; Kawano M; Matsumoto Y; Watabe T; Kodama M; Hashimoto K; Sawada K; Hatazawa J; Kimura T
Sci Rep; 2021 Jan; 11(1):2257. PubMed ID: 33500424
[TBL] [Abstract][Full Text] [Related]
33. F-18 FDG PET/CT imaging of cortical bone metastases.
Johnson GH; Mitchell LA; Brown JM
Clin Nucl Med; 2009 Nov; 34(11):802-5. PubMed ID: 19851181
[No Abstract] [Full Text] [Related]
34. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
Du Y; Cullum I; Illidge TM; Ell PJ
J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
[TBL] [Abstract][Full Text] [Related]
35. Comparison of 18F-FDG PET and bone scintigraphy in detection of bone metastases of thyroid cancer.
Ito S; Kato K; Ikeda M; Iwano S; Makino N; Tadokoro M; Abe S; Nakano S; Nishino M; Ishigaki T; Naganawa S
J Nucl Med; 2007 Jun; 48(6):889-95. PubMed ID: 17504877
[TBL] [Abstract][Full Text] [Related]
36. Granulocyte Colony-Stimulating Factor Administration at 1 Hour Before 18F-FDG PET Does Not Increase Bone Marrow FDG Accumulation.
Kawabata K; Hosono M; Tanaka H; Hyuga M; Kanagaki M
Clin Nucl Med; 2021 Sep; 46(9):770-771. PubMed ID: 33883491
[TBL] [Abstract][Full Text] [Related]
37. Accuracy of fluorodeoxyglucose-positron emission tomography for diagnosis of single bone metastasis: comparison with bone scintigraphy.
Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
J Comput Assist Tomogr; 2007; 31(5):812-9. PubMed ID: 17895798
[TBL] [Abstract][Full Text] [Related]
38. Positron Emission Tomography/Computed Tomography Findings of Granulocyte Colony-stimulating Factor-producing Lung Cancer.
Okano Y; Morishita A; Naruse K; Takeuchi E
Intern Med; 2022 Jul; 61(14):2241-2242. PubMed ID: 34980799
[No Abstract] [Full Text] [Related]
39. FDG PET/CT flip flop phenomenon in treated lymphoma of bone.
Lin EC
Clin Nucl Med; 2006 Dec; 31(12):803-5. PubMed ID: 17117078
[TBL] [Abstract][Full Text] [Related]
40. Fluorodeoxyglucose Uptake on Positron Emission Tomography Is a Useful Predictor of Long-Term Pain Control After Palliative Radiation Therapy in Patients With Painful Bone Metastases: Results of a Single-Institute Prospective Study.
Tahara T; Fujii S; Ogawa T; Michimoto K; Fukunaga T; Tanino T; Uchida N; Matsuki T; Sakamoto H
Int J Radiat Oncol Biol Phys; 2016 Feb; 94(2):322-8. PubMed ID: 26853340
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
